v3.26.3
Summary of Significant Accounting Policies - Additional Information (Details)
SFr in Millions
3 Months Ended 9 Months Ended
May 22, 2026
USD ($)
May 22, 2026
CHF (SFr)
Sep. 30, 2026
USD ($)
Jun. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
segment
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Summary Of Significant Accounting Policies [Line Items]                  
Settlement agreement           $ 36,000,000.0      
Payment term           4 years      
Accrued legal settlement charges       $ 7,000,000.0   $ 8,000,000.0      
Number of installment terms | segment           4      
Operating lease impairment charge     $ 0   $ 0   $ 0 $ 0  
Equity method investment     125,538,000       125,538,000   $ 60,351,000
Impairment charges     0       0    
Loss from equity method investment     $ (6,734,000)   $ (2,724,000)   $ (16,240,000) $ (9,641,000)  
Insulin Pump                  
Summary Of Significant Accounting Policies [Line Items]                  
Warranty period offered             4 years    
Single-use Insulin Cartridges And Infusion Sets                  
Summary Of Significant Accounting Policies [Line Items]                  
Warranty period offered             6 months    
CeQur SA                  
Summary Of Significant Accounting Policies [Line Items]                  
Payments to acquire equity method investments $ 81,400,000 SFr 64.0              
Equity method investment, ownership percentage (less than) 50.00% 50.00%              
Patents                  
Summary Of Significant Accounting Policies [Line Items]                  
Intangible assets, net           $ 13,300,000      
Amortization period           7 years